glp 1 eczema GLP-1RA & Inflammatory Skin Diseases Photodistributed exfoliative dermatitis associated with

2 CKD confirmatory secondary endpoints Significant 18% RRR of MACE with Ozempic 2 For adults with T2D and CKD, for a confirmatory secondary endpoint: Time to first occurrence of MACE (CV death, nonfatal MI, or nonfatal stroke) vs placebo when both were added to standard of care 1,2 Time to first MACE 1-3,w-z 1-3,w-z w Cumulative incidence estimates are based on time from randomization to first EAC-confirmed MACE with non-CV death modelled as a competing risk using the Aalen-Johnson estimator

and (iii) to weigh the current warnings about GLP-1 RAs against the potential for future discoveries regarding their benefits

doi: 10.1016/j.biopha.2024.116324 52 FanZWirthAKChenDWruckCJRauhMBuchfelderMet al

Want to lose belly fat